Jinri Toutiao

The State Drug Administration held a video conference on the deployment of novel coronavirus's quality and safety supervision of vaccines and therapeutic drugs.

On December 8, the State Drug Administration organized a video conference to deploy and strengthen the supervision of the quality and safety of novel coronavirus vaccines and therapeutic drugs. Huang Guo, member of the party leading group and deputy director of the State Drug Administration, attended the meeting and made a speech.

The first is to strengthen vaccine supervision.Strengthen the supervision and inspection of production links, consolidate the main responsibility of enterprise quality, urge enterprises to establish and effectively operate a quality management system, standardize the management of vaccine storage and transportation in relevant units, and ensure that the whole process meets the requirements. Strengthen the capacity-building of vaccine inspection and testing. According to the duty, do a good job of monitoring and evaluation of suspected abnormal reaction to vaccination, and actively cooperate with the investigation and diagnosis work. Special emphasis was placed on the recent approval to be included in the quality supervision of the emergency use of novel coronavirus vaccine.

The second is to strengthen the supervision of COVID-19 's treatment drugs.Strengthen supervision and inspection and product sampling inspection for therapeutic drugs such as Azvudine tablets, urge enterprises to continue to comply with production regulations, strictly carry out change research and management, and organize production in strict accordance with approved prescriptions and processes.

The third is to strengthen the supervision of COVID-19 's treatment of traditional Chinese medicine.Proprietary Chinese medicines, prepared slices of traditional Chinese medicine, and granules of traditional Chinese medicine formulations that are highly concerned by the masses, listed in COVID-19 's diagnosis and treatment Plan (trial Ninth Edition) and local COVID-19 's diagnosis and treatment plan should be combined with the characteristics of the varieties of traditional Chinese medicine. targeted supervision should be strengthened.

The fourth is to strengthen the supervision of circulation.Supervise and urge enterprises to strictly abide by the quality management standards of drug management, especially pay close attention to the operating channels of key varieties, and urge enterprises to ensure clear accounts, standardized storage and operational compliance; supervise and urge retail enterprises to strengthen the management of purchasing channels and pharmaceutical services, implement the requirements of selling prescription drugs by prescription; supervise third-party platforms and online drug sales enterprises to implement the main responsibility.

The fifth is to prevent related products from flowing into illegal channels.All provincial drug administrations should urge holders to establish an information traceability system to achieve traceable sources and traceability of relevant drug vaccines. Clinical trial sponsors / applicants, clinical trial institutions and drug inspection institutions should all strengthen their own management and strictly prevent trial or laboratory drugs from flowing into illegal channels.

General trend prospect

Overnight Chinese stocks led the gains in strong semiconductors and medical sectors.

Us stocks closed overnight, with the Dow up 183.56, or 0.55%, at 33781.48; the Nasdaq was up 123.45, or 1.13%, at 11082.00; and the S & P 500 was up 29.59, or 0.75%, at 3963.51. Chinese stocks showed a strong performance, with semiconductors and medical sectors leading the way. The ADR index of Hong Kong stocks rose to close at 19505 on a pro rata basis, up 54.89 points or 0.28% from the close in Hong Kong. The dollar fell as investors weighed the prospect of a Fed rate hike and the possibility of a recession.

Hot spot prospect

The Shanghai headquarters of the people's Bank of China and the Shanghai Banking and Insurance Supervision Bureau held a forum on financial support for the steady and healthy development of the real estate market in Shanghai.

On December 8, the Shanghai headquarters of the people's Bank of China and the Shanghai Banking and Insurance Regulatory Bureau, together with the Shanghai Securities Regulatory Bureau, the Shanghai Housing Administration and the Shanghai Local Financial Regulatory Administration, organize financial institutions and real estate enterprises under their jurisdiction to hold a forum on Shanghai's financial support for the stable and healthy development of the real estate market to learn to convey the spirit of the recent real estate financial policy document of "one party and two sessions". We will deploy and implement 16 measures to support the stable and healthy development of the real estate market and 5 measures to adjust and optimize equity financing for real estate enterprises, and take more measures to do a good job in financial support for the stable and healthy development of the real estate market. Shanghai Stock Exchange, three commercial banks, one securities company, one asset management company, one trust company and five real estate enterprises attended the meeting.

The average daily sales of antigen self-test boxes increased by more than 400 times and were partially out of stock.Relevant enterprises step up production

Following the rise in prices and shortage of drugs such as Lianhua Qingwen and ibuprofen in the market, antigen detection kits have also been out of stock in some pharmacies and e-commerce platforms in the past few days. The reporter learned through field visits and multi-party interviews that the sales of related goods such as antigen detection kits and ibuprofen on several Internet health platforms have soared recently. Wantai Biology and other related industrial companies said that there is a great demand for COVID-19 antigen reagents in the market, and the company is stepping up production.

Nine Maojiu (09922) was reduced 48 million shares by Guan Yihong, the controlling shareholder.

Zhitong Financial APP News, Nine Mao Nine (09922) announced that the company's board of directors had been informed by the executive director, chairman of the board, group chief executive and controlling shareholder Guan Yihong that on December 8, 2022, GYH J Limited (a company wholly owned by Guan Yihong) had sold a total of 48 million of the company's shares to an independent buyer through over-the-counter bulk transactions. Approximately 3.3% of the total issued share capital of the company as at the date of this announcement, with a total consideration of HK $888 million.

JD Health (06618): the stock of affordable anti-epidemic drugs exceeds 100 million boxes.

JD Health data show that drugs with significant growth in online sales include cold drugs, fever-relieving, cough-relieving, antibacterial and anti-inflammatory drugs. The turnover of these drugs has increased 18 times over October in the past 7 days. The number of TOP6 drugs sold are Lianhua Qingwen capsule, Ganmaoling granule, Pudi Blue Antiphlogistic tablet, compound paracetamol and amylamine tablets, ibuprofen sustained-release capsules, and acetaminophen. Among them, the search for Lianhua Qingwen increased by 2000 times compared with the same period last year. JD Health said that he will work with dozens of pharmaceutical companies at home and abroad to ensure stable prices of anti-epidemic prevention-related drugs in the market. JD.com Pharmacy is providing more than 100 million boxes of medicines to the public at low prices.

Beijing online Beijing antigen

A few days ago, Beijing has deployed the application of "Beijing Antigen" Mini Program. Residents can search for "Beijing Antigen" Mini Program through Wechat or Alipay, fill in personal information, read the "Antigen self-Test course" and carry out personal antigen self-test and upload test results. and can report the antigen test situation of the family members. In addition, "Beijing Antigen" Mini Program also supports residents to report fever, dry cough and other related symptom information.

Shenzhen: December 9 launched subsidy activities for the purchase of consumer electronics and household appliances

According to the Shenzhen Municipal Bureau of Commerce, the third round of "Tesco Shenzhen" consumer electronics and household appliances purchase subsidies will be launched on December 9, 2022. The subsidy is "buy-and-go". Consumers can get the required denomination coupons and purchase qualified consumer electronics and household appliances at the offline stores of the participating sales enterprises according to their personal needs, with a maximum subsidy of 15% of the sales price.

Individual stocks are sunny.

Dongyue Group (00189): all-iron flow battery has been opened to benefit from industrial battery diaphragm.

Guotai Junan released a research report that all-iron flow battery has the same intrinsic safety as all-vanadium flow battery and iron-chromium flow battery, and is suitable for large-scale electrochemical energy storage, and the active element of its electrolyte is iron, so the material cost can be greatly reduced. And almost non-toxic.

The bank believes that the development of all-iron flow batteries will inject new impetus into the industrialization process of liquid flow energy storage technology, because the overall structure of the stack has not changed much, so the relevant enterprises of stack components will benefit, including stack materials, control systems, and so on.

The company's new 10,000-ton PVDF project was completed in October and officially put into production before the end of the year, while other new production capacity in the industry will not be released until the end of the year or early next year at the earliest, so PVDF prices are expected to remain high in the second half of the year, while R142b prices as raw materials will also be supported.